Contact OnePath and get connected with a Case Manager.
Your doctor can decide if home infusion is medically appropriate for you. Patients, including those on Medicare, may be eligible to receive VPRIV infusions in their homes, as coverage allows. Additional authorization may be needed from the patient's insurance company.
A OnePath Case Manager can help you answer questions related to verification of benefits and preauthorizations for home infusions. If home infusions are approved by your physician, a case manager can work with you to help manage the transition.
VPRIV® (velaglucerase alfa for injection) is a prescription medication indicated for long-term enzyme replacement therapy (ERT) for patients with type 1 Gaucher disease.